Search dm+d | Analyse prescribing for this drug | See prices paid for this drug and its variants
Description | Depo-Medrone with Lidocaine suspension for injection 1ml vials (Pfizer Ltd) |
BNF code | 1001022K0BBAGAG |
Virtual Medicinal Product | Methylprednisolone 40mg/1ml / Lidocaine 10mg/1ml (1%) suspension for injection vials |
Name | Depo-Medrone with Lidocaine suspension for injection 1ml vials |
Abbreviated name | Depo-Medrone with Lidocaine inj 1ml vials |
Date of name applicability | 21 Jun 2004 |
Previous name | Depo-Medrone with Lidocaine injection 1ml vials |
Supplier | Pfizer Ltd |
Current licensing authority | Medicines - MHRA/EMA |
EMA additional monitoring | ✗ |
Parallel import | ✗ |
Restrictions on availability | None |
Licensed Route | |
---|---|
Licenced route | Intraarticular |
Licensed Route | |
Licenced route | Periarticular |
Licensed Route | |
Licenced route | Intrabursal |
Actual Medicinal Product Packs | |
Depo-Medrone with Lidocaine suspension for injection 1ml vials (Pfizer Ltd) 10 vial | |
Depo-Medrone with Lidocaine suspension for injection 1ml vials (Pfizer Ltd) 1 vial |
dm+d data retrieved from TRUD: release NHSBSA_3.1.0_20250310000001, imported on 11th March 2025 at 03:57:45.